Nationwide surveillance of the antimicrobial susceptibility of Chlamydia trachomatis from male urethritis in Japan: Comparison with the first surveillance report. Issue 1 (January 2022)
- Record Type:
- Journal Article
- Title:
- Nationwide surveillance of the antimicrobial susceptibility of Chlamydia trachomatis from male urethritis in Japan: Comparison with the first surveillance report. Issue 1 (January 2022)
- Main Title:
- Nationwide surveillance of the antimicrobial susceptibility of Chlamydia trachomatis from male urethritis in Japan: Comparison with the first surveillance report
- Authors:
- Takahashi, Satoshi
Yasuda, Mitsuru
Wada, Koichiro
Matsumoto, Masahiro
Hayami, Hiroshi
Kobayashi, Kanao
Miyazaki, Jun
Kiyota, Hiroshi
Matsumoto, Tetsuya
Yotsuyanagi, Hiroshi
Tateda, Kazuhiro
Sato, Junko
Hanaki, Hideaki
Masumori, Naoya
Hiyama, Yoshiki
Egawa, Shin
Yamada, Hiroki
Matsumoto, Kazumasa
Ishikawa, Kiyohito
Yamamoto, Shingo
Togo, Yoshikazu
Tanaka, Kazushi
Shigemura, Katsumi
Uehara, Shinya
Kitano, Hiroyuki
Kiyoshima, Keijiro
Hamasuna, Ryoichi
Ito, Kenji
Hirayama, Hideo
Kawai, Shuichi
Shiono, Yutaka
Maruyama, Takahiro
Ito, Shin
Yoh, Mutsumasa
Ito, Masayasu
Hatano, Koichi
Ihara, Hideari
Uno, Satoshi
Monden, Koichi
Yokoyama, Teruhiko
Takayama, Kazuo
Sumii, Toru
Kadena, Hitoshi
Kawahara, Motoshi
Hosobe, Takahide
Izumitani, Masanobu
Kano, Motonori
Nishimura, Hirofumi
Fujita, Ryuji
Kaji, Shinichi
Hayashi, Kenji
Tojo, Takanori
Matumura, Masaru
… (more) - Abstract:
- Abstract: The Urogenital Sub-committee and the Surveillance Committee of the Japanese Society of Chemotherapy, The Japanese Association for Infectious Diseases, and the Japanese Society for Clinical Microbiology conducted the second nationwide surveillance of the antimicrobial susceptibility of Chlamydia trachomatis . In this second surveillance study, clinical urethral discharge specimens were collected from patients with urethritis in 26 hospitals and clinics from May 2016 to July 2017. Based on serial cultures, the minimum inhibitory concentration (MIC) could be determined for 41 isolates; the MICs (MIC90 ) of ciprofloxacin, levofloxacin, tosufloxacin, sitafloxacin, doxycycline, minocycline, erythromycin, clarithromycin, azithromycin and solithromycin were 2 μg/ml (2 μg/ml), 1 μg/ml (0.5 μg/ml), 0.25 μg/ml (0.25 μg/ml), 0.125 μg/ml (0.063 μg/ml), 0.125 μg/ml (0.125 μg/ml), 0.25 μg/ml (0.25 μg/ml), 0.031 μg/ml (0.031 μg/ml), 0.25 μg/ml (0.125 μg/ml), and 0.016 μg/ml (0.008 μg/ml), respectively. In summary, this surveillance project did not identify any strains resistant to fluoroquinolone, tetracycline, or macrolide agents in Japan. In addition, the MIC of solithromycin was favorable and lower than that of other antimicrobial agents. However, the MIC of azithromycin had a slightly higher value than that reported in the first surveillance report, though this might be within the acceptable margin of error. Therefore, the susceptibility of azithromycin, especially, should beAbstract: The Urogenital Sub-committee and the Surveillance Committee of the Japanese Society of Chemotherapy, The Japanese Association for Infectious Diseases, and the Japanese Society for Clinical Microbiology conducted the second nationwide surveillance of the antimicrobial susceptibility of Chlamydia trachomatis . In this second surveillance study, clinical urethral discharge specimens were collected from patients with urethritis in 26 hospitals and clinics from May 2016 to July 2017. Based on serial cultures, the minimum inhibitory concentration (MIC) could be determined for 41 isolates; the MICs (MIC90 ) of ciprofloxacin, levofloxacin, tosufloxacin, sitafloxacin, doxycycline, minocycline, erythromycin, clarithromycin, azithromycin and solithromycin were 2 μg/ml (2 μg/ml), 1 μg/ml (0.5 μg/ml), 0.25 μg/ml (0.25 μg/ml), 0.125 μg/ml (0.063 μg/ml), 0.125 μg/ml (0.125 μg/ml), 0.25 μg/ml (0.25 μg/ml), 0.031 μg/ml (0.031 μg/ml), 0.25 μg/ml (0.125 μg/ml), and 0.016 μg/ml (0.008 μg/ml), respectively. In summary, this surveillance project did not identify any strains resistant to fluoroquinolone, tetracycline, or macrolide agents in Japan. In addition, the MIC of solithromycin was favorable and lower than that of other antimicrobial agents. However, the MIC of azithromycin had a slightly higher value than that reported in the first surveillance report, though this might be within the acceptable margin of error. Therefore, the susceptibility of azithromycin, especially, should be monitored henceforth. … (more)
- Is Part Of:
- Journal of infection and chemotherapy. Volume 28:Issue 1(2022)
- Journal:
- Journal of infection and chemotherapy
- Issue:
- Volume 28:Issue 1(2022)
- Issue Display:
- Volume 28, Issue 1 (2022)
- Year:
- 2022
- Volume:
- 28
- Issue:
- 1
- Issue Sort Value:
- 2022-0028-0001-0000
- Page Start:
- 1
- Page End:
- 5
- Publication Date:
- 2022-01
- Subjects:
- Chlamydia trachomatis -- Antimicrobial susceptibility -- Surveillance
Chemotherapy -- Periodicals
Infection -- Periodicals
Communicable diseases -- Chemotherapy -- Periodicals
615.5805 - Journal URLs:
- http://www.sciencedirect.com/science/journal/1341321X ↗
http://link.springer-ny.com/link/service/journals/10156/index.htm ↗
http://www.springerlink.com/content/1341-321x ↗
http://www.elsevier.com/journals ↗
http://firstsearch.oclc.org ↗ - DOI:
- 10.1016/j.jiac.2021.09.012 ↗
- Languages:
- English
- ISSNs:
- 1341-321X
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 5006.691000
British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store - Ingest File:
- 22696.xml